It’s hard to beat our experience. For over 30 years, Sightpath Medical has worked with surgeons and facilities across the nation to provide patients with better vision. Cataract and refractive surgeries have seen dramatic changes in technology over the past decades. We’ve been there through it all.
Sightpath Medical values innovation and cutting-edge technologies. Because of this, we are also a company of firsts.
We are the first to mobilize:
Phaco machines. In 1991, six years after the technology was introduced, we successfully mobilized phacoemulsification technology, making it possible for surgeons and facilities across the country to perform cataract surgery, no matter their location.
The excimer laser. Two years after LASIK received FDA approval, our employees were the first to mobilize the excimer laser for refractive surgery.
The IntraLase Femtosecond Laser. In 2007, we made history by mobilizing the IntraLase Femtosecond Laser.
The LenSx Femtosecond Laser. We mobilized the Alcon LenSx Femtosecond Laser in 2012, making us the first company to offer mobilized laser-assisted cataract surgery services.
The Centurion Vision System. When the Alcon Centurion phaco machine was released in 2014, we quickly mobilized it. We were eager to give our customers the next level in phaco technology.
The iFS Advanced Femtosecond Laser. Within a year of its release, Sightpath Medical successfully mobilized Johnson & Johnson’s iFS Advanced Femtosecond Laser.
A research team composed of scientists from the Philippines, United Kingdom, and the United States found that – compared to manual clear corneal incisions (CCI) – femtosecond laser-constructed incisions achieve better wound sealability, a quality that may reduce the risk of surgical complications.
Despite its high success rate, LASIK has been plagued with numerous myths that keep people from pursuing the surgery. What are some common myths associated with LASIK, and how should you debunk them?